High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma
2011

High p300 Expression Linked to Poor Prognosis in Liver Cancer

Sample size: 123 publication 10 minutes Evidence: moderate

Author Information

Author(s): Li Mei, Luo Rong-Zhen, Chen Jie-Wei, Cao Yun, Lu Jia-Bin, He Jie-Hua, Wu Qiu-Liang, Cai Mu-Yan

Primary Institution: State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, PR China

Hypothesis

The expression dynamics of p300 in hepatocellular carcinoma (HCC) and its clinical significance are unclear.

Conclusion

High expression of p300 in HCC is associated with aggressive features and poor patient prognosis.

Supporting Evidence

  • High p300 expression was found in 60 out of 123 HCC cases.
  • High p300 expression correlated with larger tumor size and poorer differentiation.
  • Patients with high p300 expression had significantly shorter survival times.

Takeaway

This study found that when a protein called p300 is found in high amounts in liver cancer, it can mean the cancer is more aggressive and the patient may not live as long.

Methodology

The study used RT-PCR, Western blotting, and immunohistochemistry to analyze p300 expression in HCC tissues.

Potential Biases

Potential biases in patient selection and data interpretation may exist.

Limitations

The study may not account for all potential confounding factors affecting prognosis.

Participant Demographics

The cohort included 107 men (87%) and 16 women (13%) with a mean age of 47.7 years.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI not specified

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-9-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication